Wells Fargo & Company MN Purchases 5,704 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Wells Fargo & Company MN grew its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 16.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 41,161 shares of the technology company’s stock after buying an additional 5,704 shares during the quarter. Wells Fargo & Company MN owned 0.20% of Simulations Plus worth $1,148,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the company. Jones Financial Companies Lllp boosted its holdings in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after purchasing an additional 427 shares during the last quarter. AlphaQuest LLC boosted its holdings in Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after purchasing an additional 2,243 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in Simulations Plus in the fourth quarter worth approximately $86,000. Quantbot Technologies LP boosted its holdings in Simulations Plus by 191.6% in the fourth quarter. Quantbot Technologies LP now owns 5,371 shares of the technology company’s stock worth $150,000 after purchasing an additional 3,529 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in Simulations Plus by 14.3% in the fourth quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after purchasing an additional 713 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This trade represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 19.40% of the company’s stock.

Simulations Plus Stock Down 0.8 %

SLP opened at $35.21 on Tuesday. The stock’s fifty day moving average is $28.42 and its two-hundred day moving average is $30.29. The company has a market capitalization of $708.11 million, a P/E ratio of 88.03 and a beta of 1.13. Simulations Plus, Inc. has a 52 week low of $23.01 and a 52 week high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.06. The business had revenue of $22.43 million for the quarter, compared to analysts’ expectations of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business’s revenue for the quarter was up 22.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 EPS. Equities analysts anticipate that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Analyst Upgrades and Downgrades

SLP has been the topic of several recent research reports. StockNews.com raised Simulations Plus from a “sell” rating to a “hold” rating in a research note on Monday. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. Finally, KeyCorp boosted their price objective on Simulations Plus from $32.00 to $40.00 and gave the company an “overweight” rating in a research note on Wednesday, April 16th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $50.00.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.